Introduction: Conclusive findings about hepatic bile acid(BA) composition in NAFLD have not been established. We suppose that findings of hepatic BA composition may be related to both steatosis and accompanied diseases such as obesity or diabetes mellitus, however, it is unknown how hepatic BA composition alter in the process of steatosis. The aim of this study was to investigate alteration of hepatic BA composition in NAFLD model without obesity or diabetes mellitus. Methods: Wistar Kyoto rats were randomly assigned(n=6/group) to be fed with either normal chow diet or choline-deficient(CD) diet for 5 weeks. Two groups were studied: (a)WKY fed with normal diet(WKY-N) and (b)WKY fed with choline-deficient diet(WKY-CD). Hepatic BAs analysis was performed by liquid chromatography-electrospray ionization-tandem mass spectrometry technique. Results: 1. Histopathological findings:Livers of WKY-CD showed steatosis, whereas there was no steatosis in livers of SHR-N. 2. BA composition in WKY—N: In primary BAs of WKY-N, CA species, CDCA species, alpha-MCA species, beta-MCA species, HCA species were 174.9±27.9 nmol/g, 30.3±6.8nmol/g, 22.0±3.4nmol/g, 141.6 ±23.9nmol/g, and 14.0±4.1 nmol/g respectively, whereas in secondary BAs of WKY-N, DCA species, LCA species, UDCA species, HDCA species, omega-species, and MDCA species were 2.6± 0.8nmol/g, 0.0± 0.0nmol/g, 0.5± 0.5nmol/g, 31.0± 9.8nmol/g, 1.1± 0.4nmol/g, and 0± 0nmol/g, respectively. 3. Alteration of BA composition:In BAs of WKY-CD, CA species, CDCA species, alpha-MCA species, beta-MCA species, HCA species, DCA species, LCA species, UDCA species, HDCA species, omega-species, and MDCA were 81.8±16.5 nmol/g, 25.8± 7.9 nmol/g, 19.1±9.2 nmol/g, 125.5±81.3 nmol/g, 9.1±7.2 nmol/g, 4.0±4.7 nmol/g, 0±0 nmol/g, 2.5±1.0 nmol/g, 28.1±31.9 nmol/g, 6.3±3.0 nmol/g, and 0±0 nmol/g, respectively. The alteration of other BAs except for CA species was minor or slight in WKY-CD. 4. Hepatic mRNA expression of key genes involved in BA synthesis:In WKY-CD, mRNA expression of cyp27a1, which is associated with metabolism to CDCA, increased significantly. Conclusion: We demonstrated that CA species in hepatic BA compositions decreased largely in the process of steatosis when NAFLD did not be accompanied with obesity or diabetes mellitus.
Read full abstract